Daré Bioscience, a biotech company focused on women's health, has launched a nationwide virtual bus tour webinar series to engage investors. The series, hosted by CEO Sabrina Martucci Johnson, will provide updates on the company's commercial strategy, product portfolio, and growth opportunities, along with live Q&A sessions. The initiative aims to maintain open communication with shareholders and inform them about Daré's ongoing Regulation A offering. Investors can attend multiple regional-themed webinars scheduled through August, with replays available online.
Swiss bank UBS significantly increased its exposure to BlackRock's iShares Bitcoin Trust (IBIT) in Q2 by raising call option holdings 24-fold to 1.95 million shares and increasing direct IBIT shares by 12% to 407,890. Meanwhile, its put option exposu...
HIVE Digital Technologies reported a 73.5% year-over-year revenue increase to $79.1 million in Q1 FY2027, fueled by higher Bitcoin production and expanding high-performance computing (HPC) services. The company received 1,004 Bitcoin rewards, a 147% ...
AMD revealed a $565 million stake in SpaceX following its June IPO, despite SpaceX's decision to use Nvidia chips exclusively for its AI infrastructure. While Nvidia's investment aligns with its chip supply role, AMD's smaller stake appears to be a f...
KeyCorp reported strong second-quarter results, with net interest income rising 10% and an improved preferred dividend coverage ratio of 7%. The bank's aggressive share buyback program, exceeding $700 million in the first half of the year, has reduce...
Cisco Systems and Broadcom both posted strong quarterly results driven by AI infrastructure demand but took different approaches. Cisco's growth came from enterprise networking upgrades, with AI orders surpassing $9 billion for the year and a broad c...
